Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
151
datasets available to search
ShareScore release 0.9.0
Dataset results
151 results for “Herpes Zoster”
VZV-specific T cell clonotypes following recovery from herpes zoster
<p>These are TRB sequences, obtained from Adaptive Biotechnology v4b Immunoseq assay, for PBMC and skin biopsy (rash site and uninvolved contralateral site) samples over a time-course (day 45, day 90, day 360) following the onset of herpes zoster in one human subject. Additionally, HLA-A*02:01- tetramer-sorted repertoires were obtained representing varicella-zoster virus specific CD8 T cell clonotypes. </p>
Search strategies for herpes zoster vaccination for adults
<p>The dataset includes the complete, reproducible search strategies for all literature databases searched during this project. The search strategies were designed to answer the following research questions:</p> <ul> <li>RQ 1 – What is the clinical efficacy and effectiveness of the currently licensed and approved recombinant vaccine for the prevention of herpes zoster and associated complications, in adults aged 50 years and older and in adults aged 18 and over who are at increased risk of herpes zoster?</li> <li>RQ 2 – What is the safety profile of the currently licensed and approved recombinant vaccine for the prevention of herpes zoster in adults aged 50 years and older and in adults aged 18 and over who are at increased risk of herpes zoster?</li> </ul> <p> </p>
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster
ClinicalTrials.gov study NCT01827839. IPD Sharing: YES. Countries: 2. Publications: 1.
Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional
ClinicalTrials.gov study NCT02735915. IPD Sharing: YES. Countries: 3. Publications: 2.
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5
ClinicalTrials.gov study NCT02581410. IPD Sharing: YES. Countries: 1. Publications: 2.
A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subun
ClinicalTrials.gov study NCT02723773. IPD Sharing: YES. Countries: 18. Publications: 3.
A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the V
ClinicalTrials.gov study NCT04176939. IPD Sharing: YES. Countries: 7. Publications: 0.
Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adu
ClinicalTrials.gov study NCT02979639. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
ClinicalTrials.gov study NCT01610414. IPD Sharing: Not stated. Countries: 28. Publications: 4.
A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults
ClinicalTrials.gov study NCT05966090. IPD Sharing: YES. Countries: 2. Publications: 0.
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
ClinicalTrials.gov study NCT01165203. IPD Sharing: YES. Countries: 3. Publications: 1.
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
ClinicalTrials.gov study NCT00802464. IPD Sharing: YES. Countries: 3. Publications: 1.
Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
ClinicalTrials.gov study NCT01165177. IPD Sharing: YES. Countries: 18. Publications: 13.
Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) St
ClinicalTrials.gov study NCT02690207. IPD Sharing: YES. Countries: 18. Publications: 1.
Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers
ClinicalTrials.gov study NCT01767467. IPD Sharing: Not stated. Countries: 21. Publications: 2.
Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
ClinicalTrials.gov study NCT03798691. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zos
ClinicalTrials.gov study NCT04091451. IPD Sharing: YES. Countries: 1. Publications: 2.
Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus a
ClinicalTrials.gov study NCT02052596. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India
ClinicalTrials.gov study NCT05219253. IPD Sharing: YES. Countries: 1. Publications: 2.
Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years
ClinicalTrials.gov study NCT01777321. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.